Talisman Therapeutics Limited
Rick Livesey is currently serving as the Chief Executive Officer at Talisman Therapeutics Limited and GEN2 NEUROSCIENCE LTD. Prior to this, Rick held various senior positions in the field of neuroscience research at companies like Biogen. Rick has an impressive educational background, with a BSc in Neurobiology and Anatomy from University College Cork and an MB/PhD in Medicine specializing in neuroscience from the University of Cambridge. Throughout their career, Rick has also held academic positions at institutions like UCL, University of Cambridge, and Harvard Medical School.
This person is not in any teams
Talisman Therapeutics Limited
Talisman Therapeutics is a human stem cell drug discovery company, based in Cambridge, UK. We are committed to revolutionising the discovery of treatments for Alzheimer’s disease (AD). Our novel human stem cell models of AD provide a transformative platform for rapid and more therapeutically relevant compound identification, thereby offering the potential to significantly accelerate drug discovery and, more importantly, de-risk subsequent development.